{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T20:11:23Z","timestamp":1770754283802,"version":"3.50.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T00:00:00Z","timestamp":1569369600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000266","name":"Engineering and Physical Sciences Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Oncolytics"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.omto.2019.09.003","type":"journal-article","created":{"date-parts":[[2019,9,28]],"date-time":"2019-09-28T01:46:52Z","timestamp":1569635212000},"page":"117-130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Calcium Influx Caused by ER Stress Inducers Enhances Oncolytic Adenovirus Enadenotucirev Replication and Killing through PKC\u03b1 Activation"],"prefix":"10.1016","volume":"15","author":[{"given":"William K.","family":"Taverner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Egon J.","family":"Jacobus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Christianson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Champion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrienne W.","family":"Paton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James C.","family":"Paton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiheng","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan","family":"Cawood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Len W.","family":"Seymour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet","family":"Lei-Rossmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.omto.2019.09.003_bib1","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/nbt.2287","article-title":"Oncolytic virotherapy","volume":"30","author":"Russell","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omto.2019.09.003_bib2","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/bjc.2015.481","article-title":"Oncolytic viruses: finally delivering","volume":"114","author":"Seymour","year":"2016","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.omto.2019.09.003_bib3","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/mt.2013.220","article-title":"Oncolytic virotherapy and immunogenic cancer cell death: sharpening the sword for improved cancer treatment strategies","volume":"22","author":"Workenhe","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omto.2019.09.003_bib4","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s00109-016-1453-9","article-title":"Oncolytic viruses-immunotherapeutics on the rise","volume":"94","author":"Keller","year":"2016","journal-title":"J.\u00a0Mol. Med. (Berl.)"},{"key":"10.1016\/j.omto.2019.09.003_bib5","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.omto.2016.11.003","article-title":"Oncolytic Group B Adenovirus Enadenotucirev Mediates Non-apoptotic Cell Death with Membrane Disruption and Release of Inflammatory Mediators","volume":"4","author":"Dyer","year":"2016","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.omto.2019.09.003_bib6","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nrc3770","article-title":"Going viral with cancer immunotherapy","volume":"14","author":"Lichty","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.omto.2019.09.003_bib7","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.15252\/emmm.201707567","article-title":"Oncolytic adenovirus expressing bispecific antibody targets T-cell cytotoxicity in cancer biopsies","volume":"9","author":"Freedman","year":"2017","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.omto.2019.09.003_bib8","doi-asserted-by":"crossref","first-page":"6852","DOI":"10.1158\/0008-5472.CAN-18-1750","article-title":"An Oncolytic Virus\u00a0Expressing a T-cell Engager Simultaneously Targets Cancer and Immunosuppressive Stromal Cells","volume":"78","author":"Freedman","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.omto.2019.09.003_bib9","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nrm2199","article-title":"Signal integration in the endoplasmic reticulum unfolded protein response","volume":"8","author":"Ron","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.omto.2019.09.003_bib10","doi-asserted-by":"crossref","first-page":"a013169","DOI":"10.1101\/cshperspect.a013169","article-title":"Endoplasmic reticulum stress sensing in the unfolded protein response","volume":"5","author":"Gardner","year":"2013","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.omto.2019.09.003_bib11","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3390\/11060393","article-title":"Synthesis and analgesic activity evaluation of some agmatine derivatives","volume":"11","author":"He","year":"2006","journal-title":"Molecules"},{"key":"10.1016\/j.omto.2019.09.003_bib12","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.trecan.2016.03.007","article-title":"Endoplasmic Reticulum Stress and the Hallmarks of Cancer","volume":"2","author":"Urra","year":"2016","journal-title":"Trends Cancer"},{"key":"10.1016\/j.omto.2019.09.003_bib13","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.tim.2005.02.004","article-title":"Hepatitis C virus, ER stress, and oxidative stress","volume":"13","author":"Tardif","year":"2005","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.omto.2019.09.003_bib14","doi-asserted-by":"crossref","first-page":"12747","DOI":"10.1128\/JVI.78.23.12747-12761.2004","article-title":"Resistance to vesicular stomatitis virus infection requires a functional cross talk between the eukaryotic translation initiation factor 2alpha kinases PERK and PKR","volume":"78","author":"Baltzis","year":"2004","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omto.2019.09.003_bib15","doi-asserted-by":"crossref","first-page":"10825","DOI":"10.1128\/JVI.78.19.10825-10828.2004","article-title":"African swine fever virus inhibits induction of the stress-induced proapoptotic transcription factor CHOP\/GADD153","volume":"78","author":"Netherton","year":"2004","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omto.2019.09.003_bib16","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1128\/JVI.76.9.4162-4171.2002","article-title":"Japanese encephalitis virus infection initiates endoplasmic reticulum stress and an unfolded protein response","volume":"76","author":"Su","year":"2002","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omto.2019.09.003_bib17","first-page":"518","article-title":"The unfolded protein response in virus infections","volume":"5","author":"Chan","year":"2014","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.omto.2019.09.003_bib18","doi-asserted-by":"crossref","first-page":"13086","DOI":"10.1128\/JVI.02156-14","article-title":"Chemical induction of unfolded protein response enhances cancer cell killing through lytic virus infection","volume":"88","author":"Prasad","year":"2014","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omto.2019.09.003_bib19","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.2174\/1381612811209023313","article-title":"Radiovirotherapy: principles and prospects in oncology","volume":"18","author":"Touchefeu","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.omto.2019.09.003_bib20","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.molmed.2013.03.001","article-title":"Advances in stem cell therapy against gliomas","volume":"19","author":"Bovenberg","year":"2013","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.omto.2019.09.003_bib21","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1158\/0008-5472.CAN-18-1326","article-title":"Antagonism of glycolysis and reductive carboxylation of glutamine potentiates activity of oncolytic adenoviruses in cancer cells","volume":"79","author":"Dyer","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.omto.2019.09.003_bib22","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1038\/onc.2013.112","article-title":"Synergistic cytotoxicity of radiation and oncolytic Lister strain vaccinia in (V600D\/E)BRAF mutant melanoma depends on JNK and TNF-\u03b1 signaling","volume":"33","author":"Kyula","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.omto.2019.09.003_bib23","doi-asserted-by":"crossref","first-page":"421","DOI":"10.2174\/1566523213666131125095046","article-title":"Adenovirus vectors for gene therapy, vaccination and cancer gene therapy","volume":"13","author":"Wold","year":"2013","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.omto.2019.09.003_bib24","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.coviro.2016.06.009","article-title":"Recent advances in oncolytic adenovirus therapies for cancer","volume":"21","author":"Rosewell Shaw","year":"2016","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.omto.2019.09.003_bib25","doi-asserted-by":"crossref","first-page":"5203","DOI":"10.1016\/j.vaccine.2011.05.025","article-title":"International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations","volume":"29","author":"Barouch","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.omto.2019.09.003_bib26","first-page":"351","article-title":"Prevalence of neutralizing antibodies to adenoviral serotypes 5 and 35 in the adult populations of The Gambia, South Africa, and the United States","volume":"11","author":"Nwanegbo","year":"2004","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"10.1016\/j.omto.2019.09.003_bib27","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/mt.2015.194","article-title":"Development of novel adenoviral vectors to overcome challenges observed with HAdV-5-based constructs","volume":"24","author":"Alonso-Padilla","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omto.2019.09.003_bib28","doi-asserted-by":"crossref","first-page":"e2409","DOI":"10.1371\/journal.pone.0002409","article-title":"Directed evolution generates a novel oncolytic virus for the treatment of colon cancer","volume":"3","author":"Kuhn","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omto.2019.09.003_bib29","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.omto.2017.03.003","article-title":"Preclinical Safety Studies of Enadenotucirev, a Chimeric Group B Human-Specific Oncolytic Adenovirus","volume":"5","author":"Illingworth","year":"2017","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.omto.2019.09.003_bib30","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s40425-017-0277-7","article-title":"Phase 1 study of intravenous administration of the chimeric adenovirus enadenotucirev in patients undergoing primary tumor resection","volume":"5","author":"Garcia-Carbonero","year":"2017","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.omto.2019.09.003_bib31","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/gt.2014.2","article-title":"Activity of a group B oncolytic adenovirus (ColoAd1) in whole human blood","volume":"21","author":"Di","year":"2014","journal-title":"Gene Ther."},{"key":"10.1016\/j.omto.2019.09.003_bib32","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.virol.2017.02.011","article-title":"Group B adenovirus enadenotucirev infects polarised colorectal cancer cells efficiently from the basolateral surface expected to be encountered during intravenous delivery to treat disseminated cancer","volume":"505","author":"Chia","year":"2017","journal-title":"Virology"},{"key":"10.1016\/j.omto.2019.09.003_bib33","doi-asserted-by":"crossref","first-page":"e0177810","DOI":"10.1371\/journal.pone.0177810","article-title":"Development of a versatile oncolytic virus platform for local intra-tumoural expression of therapeutic transgenes","volume":"12","author":"Marino","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.omto.2019.09.003_bib34","doi-asserted-by":"crossref","first-page":"10123","DOI":"10.1128\/JVI.01102-12","article-title":"Cell-free transmission of human adenovirus by passive mass transfer in cell culture simulated in a computer model","volume":"86","author":"Yakimovich","year":"2012","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omto.2019.09.003_bib35","doi-asserted-by":"crossref","first-page":"e1000440","DOI":"10.1371\/journal.ppat.1000440","article-title":"Use of tissue-specific microRNA to control pathology of wild-type adenovirus without attenuation of its ability to kill cancer cells","volume":"5","author":"Cawood","year":"2009","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.omto.2019.09.003_bib36","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/nature05124","article-title":"AB5 subtilase cytotoxin inactivates the endoplasmic reticulum chaperone BiP","volume":"443","author":"Paton","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.omto.2019.09.003_bib37","doi-asserted-by":"crossref","first-page":"e11878","DOI":"10.7554\/eLife.11878","article-title":"Ceapins are a new class of unfolded protein response inhibitors, selectively targeting the ATF6\u03b1 branch","volume":"5","author":"Gallagher","year":"2016","journal-title":"eLife"},{"key":"10.1016\/j.omto.2019.09.003_bib38","doi-asserted-by":"crossref","first-page":"5998","DOI":"10.1093\/emboj\/16.19.5998","article-title":"The role of the nuclear pore complex in adenovirus DNA entry","volume":"16","author":"Greber","year":"1997","journal-title":"EMBO J."},{"key":"10.1016\/j.omto.2019.09.003_bib39","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1600-065X.2009.00820.x","article-title":"The molecular physiology of CRAC channels","volume":"231","author":"Prakriya","year":"2009","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.omto.2019.09.003_bib40","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1042\/bj3000665","article-title":"Ionomycin enhances Ca2+ influx by stimulating store-regulated cation entry and not by a direct action at the plasma membrane","volume":"300","author":"Morgan","year":"1994","journal-title":"Biochem. J."},{"key":"10.1016\/j.omto.2019.09.003_bib41","first-page":"357","article-title":"Mechanism of action of calcium ionophores on intact cells: ionophore-resistant cells","volume":"13","author":"Dedkova","year":"2000","journal-title":"Membr. Cell Biol."},{"key":"10.1016\/j.omto.2019.09.003_bib42","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.4049\/jimmunol.165.5.2809","article-title":"Differential requirement for classic and novel PKC isoforms in respiratory burst and phagocytosis in RAW 264.7 cells","volume":"165","author":"Larsen","year":"2000","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.omto.2019.09.003_bib43","doi-asserted-by":"crossref","first-page":"28495","DOI":"10.1074\/jbc.270.48.28495","article-title":"Protein kinase C: structure, function, and regulation","volume":"270","author":"Newton","year":"1995","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omto.2019.09.003_bib44","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0014-5793(03)00780-4","article-title":"Viroporins","volume":"552","author":"Gonzalez","year":"2003","journal-title":"FEBS Lett."},{"key":"10.1016\/j.omto.2019.09.003_bib45","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.1093\/emboj\/16.12.3519","article-title":"Coxsackievirus protein 2B modifies endoplasmic reticulum membrane and plasma membrane permeability and facilitates virus release","volume":"16","author":"van Kuppeveld","year":"1997","journal-title":"EMBO J."},{"key":"10.1016\/j.omto.2019.09.003_bib46","doi-asserted-by":"crossref","first-page":"8928","DOI":"10.1158\/0008-5472.CAN-08-1145","article-title":"Bioselection of a gain of function mutation that enhances adenovirus 5 release and improves its antitumoral potency","volume":"68","author":"Gros","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/j.omto.2019.09.003_bib47","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.1038\/onc.2013.524","article-title":"Protein kinase C and cancer: what we know and what we do not","volume":"33","author":"Garg","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.omto.2019.09.003_bib48","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.1038\/sj.onc.1207118","article-title":"p300\/CBP and cancer","volume":"23","author":"Iyer","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.omto.2019.09.003_bib49","doi-asserted-by":"crossref","first-page":"40946","DOI":"10.1074\/jbc.M007832200","article-title":"Phosphorylation of p300 at serine 89 by protein kinase C","volume":"275","author":"Yuan","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omto.2019.09.003_bib50","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1099\/vir.0.19178-0","article-title":"Comparative analysis of the genome organization of human adenovirus 11, a member of the human adenovirus species B, and the commonly used human adenovirus 5 vector, a member of species C","volume":"84","author":"Mei","year":"2003","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.omto.2019.09.003_bib51","doi-asserted-by":"crossref","first-page":"5938","DOI":"10.1021\/acs.biochem.6b00858","article-title":"Protein Kinase C Signaling in Adenoviral Infection","volume":"55","author":"Yousuf","year":"2016","journal-title":"Biochemistry"},{"key":"10.1016\/j.omto.2019.09.003_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-1119(99)00249-8","article-title":"Mechanism of DNA replication in eukaryotic cells: cellular host factors stimulating adenovirus DNA replication","volume":"236","author":"de Jong","year":"1999","journal-title":"Gene"},{"key":"10.1016\/j.omto.2019.09.003_bib53","doi-asserted-by":"crossref","first-page":"10427","DOI":"10.1074\/jbc.M106955200","article-title":"YB-1 relocates to the nucleus in adenovirus-infected cells and facilitates viral replication by inducing E2 gene expression through the E2 late promoter","volume":"277","author":"Holm","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omto.2019.09.003_bib54","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.4161\/cbt.4.11.2137","article-title":"Adenoviral E1a expression levels affect virus-selective replication in human cancer cells","volume":"4","author":"Zheng","year":"2005","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.omto.2019.09.003_bib55","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41417-018-0042-1","article-title":"Turning cold tumours hot: oncolytic virotherapy gets up close and personal with other therapeutics at the 11th Oncolytic Virus Conference","volume":"26","author":"Dyer","year":"2019","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.omto.2019.09.003_bib56","first-page":"43","article-title":"New frontiers in oncolytic viruses: optimizing and selecting for virus strains with improved efficacy","volume":"12","author":"Lundstrom","year":"2018","journal-title":"Biologics"},{"key":"10.1016\/j.omto.2019.09.003_bib57","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/mt.2015.233","article-title":"Actin-resistant DNAse I expression from oncolytic adenovirus enadenotucirev enhances its intratumoral spread and reduces tumor growth","volume":"24","author":"Tedcastle","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omto.2019.09.003_bib58","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1084\/jem.20040392","article-title":"A new family of potent AB(5) cytotoxins produced by Shiga toxigenic Escherichia coli","volume":"200","author":"Paton","year":"2004","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.omto.2019.09.003_bib59","doi-asserted-by":"crossref","first-page":"4","DOI":"10.7554\/eLife.05434","article-title":"Endoplasmic reticulum stress-independent activation of unfolded protein response kinases by a small molecule ATP-mimic","volume":"4","author":"Mendez","year":"2015","journal-title":"eLife"}],"container-title":["Molecular Therapy - Oncolytics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2372770519300877?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2372770519300877?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T06:20:06Z","timestamp":1762496406000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2372770519300877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":59,"alternative-id":["S2372770519300877"],"URL":"https:\/\/doi.org\/10.1016\/j.omto.2019.09.003","relation":{},"ISSN":["2372-7705"],"issn-type":[{"value":"2372-7705","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Calcium Influx Caused by ER Stress Inducers Enhances Oncolytic Adenovirus Enadenotucirev Replication and Killing through PKC\u03b1 Activation","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Oncolytics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omto.2019.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors.","name":"copyright","label":"Copyright"}]}}